The invention relates to a method of cardiac imaging using hyperpolarised <SUP>13</SUP>C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.
申请公布号
WO2006054903(A2)
申请公布日期
2006.05.26
申请号
WO2005NO00434
申请日期
2005.11.18
申请人
GE HEALTHCARE AS;LERCHE, MATHILDE;ZANDT, RENE;GOLMAN, KLAES;THANING, MIKKEL;ARDENKJAER-LARSEN, JAN-HENRIK;PETERSSON STEFAN
发明人
LERCHE, MATHILDE;ZANDT, RENE;GOLMAN, KLAES;THANING, MIKKEL;ARDENKJAER-LARSEN, JAN-HENRIK;PETERSSON STEFAN
